Ewing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Ewing Sarcoma Clinical Trial Report Overview
A total of 434 Ewing Sarcoma clinical trials were conducted as of February 2024. The Ewing Sarcoma clinical trial report provides a comprehensive understanding of the Ewing Sarcoma clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials.
Key Regions | · North America
· Europe · Asia-Pacific · Middle East and Africa · South and Central America |
Key Countries | · The US
· China · The UK · Australia · Spain · Germany · Canada · Italy · France · Netherlands |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Merck & Co Inc
· Bristol-Myers Squibb Co · Pfizer Inc · Pharma Mar SA · Bayer AG · Eisai Co Ltd · Eli Lilly and Co |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Ewing Sarcoma Clinical Trials Segmentation by Regions and Countries
As of February 2024, North America led the Ewing Sarcoma clinical trials landscape with more than 50% of the clinical trials conducted there
The key regions considered for Ewing Sarcoma clinical trials analysis are North America, Europe, Asia-Pacific, the Middle East and Africa, and South and Central America.
In the country-wise analysis, the US had the highest number of Ewing Sarcoma clinical trials as of February 2024. Netherlands had the highest average patient enrollment in Ewing Sarcoma clinical trials during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Canda had the highest proportion of Ewing Sarcoma to Respiratory clinical trials as of February 2024.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Brazil had the highest proportion of Ewing Sarcoma to Respiratory clinical trials as of February 2024.
Ewing Sarcoma Clinical Trials Analysis by Regions, 2024 (%)
Buy the Full Report for More Regional Insights into the Ewing Sarcoma Clinical Trials
Download a Free Sample Report
Ewing Sarcoma Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Ewing Sarcoma clinical trials are company, institution, and the government. As of January 2024, more than 60% of Ewing Sarcoma clinical trials conducted were sponsored by institution sponsor type, followed by company.
Ewing Sarcoma Clinical Trials Analysis by Sponsor Types, 2024 (%)
Buy the Full Report for More Sponsor Type Insights into the Ewing Sarcoma Clinical Trials
Ewing Sarcoma Clinical Trials - Competitive Landscape
In 2024, Merck & Co Inc conducted the highest number of Ewing Sarcoma clinical trials
A few of the leading sponsors for Ewing Sarcoma clinical trials are:
- Merck & Co Inc
- Bristol-Myers Squibb Co
- Pfizer Inc
- Pharma Mar SA
- Bayer AG
- Eisai Co Ltd
- Eli Lilly and Co
Ewing Sarcoma Clinical Trials Analysis by Sponsors, 2024 (%)
Buy the Full Report to Know More about the Leading Sponsors of Ewing Sarcoma Clinical Trials
Segments Covered in the Report
Ewing Sarcoma Clinical Trials Regional Outlook (2024)
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South and Central America
Ewing Sarcoma Clinical Trials Country Outlook (2024)
- The US
- China
- The UK
- Australia
- Spain
- Germany
- Canada
- Italy
- France
- Netherlands
Ewing Sarcoma Clinical Trials Sponsor Type Outlook (2024)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Formulate key business strategies about investment.
- Identify prominent locations for conducting clinical trials which saves time and cost.
- Get top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Understand trial count and enrollment trends by country in the global therapeutics market.
- Interpret the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Understand clinical trial assessment of the indication on a global, regional, and country level.
Bristol-Myers Squibb Co
Pfizer Inc
Pharma Mar SA
Bayer AG
Eisai Co Ltd
Eli Lilly and Co
F. Hoffmann-La Roche Ltd
Novartis AG
Gradalis Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Ewing Sarcoma clinical trials in February 2024?
North America accounted for the highest number of Ewing Sarcoma clinical trials as of February 2024.
-
Which country conducted the highest number of Ewing Sarcoma clinical trials in February 2024?
The US conducted the highest number of Ewing Sarcoma clinical trials as of February 2024.
-
Which sponsor type was the most prominent in the Ewing Sarcoma clinical trials in February 2024?
As of February 2024, most of the Ewing Sarcoma clinical trials conducted were sponsored by institution sponsor type.
-
Which are the leading sponsors of Ewing Sarcoma clinical trials?
A few of the leading sponsors of Ewing Sarcoma clinical trials are Merck & Co Inc, Bristol-Myers Squibb Co, Pfizer Inc, Pharma Mar SA, Bayer AG, Eisai Co Ltd, and Eli Lilly and Co, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.